Transplantation was founded on the spirit of innovation and experimentation. The AST created the Innovation Award to honor an individual or team whose big ideas and outside the box thinking has made a significant impact on transplantation. The award is designed to showcase successes in transplant innovation and to drive, recognize, and reward novel ideas.
Visit the AST Member Spotlight page to read about Dr. Christopher's efforts to improve surgical education in his role as Associate Program Director of the general surgery residency at Northwestern Medicine.
Interested in being featured in the AST Member Spotlight? Please contact rpaulin@myast.org for more information.
The AST Research Network is offering an on-demand webinar on research grant writing. This 1-hour workshop shares tips on how to write a successful grant application from two experienced grant reviewers.
Watch kidney transplant patients talk about their diagnoses and the importance of communication with their doctors and transplant teams. For these patients, switching therapies made sense.
The OPTN has several open opportunities for your consideration including board and committee positions, public comment, surveys, and virtual regional meetings.
In the interest of facilitating patient care and advancing science and ensuring that accurate knowledge and experience is available to all during this current time of crisis, AJT has been expediting review of all papers dealing with COVID-19, as well as making them free to access for all.
The AST Research Network is now accepting applications for its annual career development grants cycle! The purpose of these grants is to foster the training of early career investigators who have the potential to contribute to transplant science/immunobiology and/or treatment of transplant recipients. The grants encourage continued commitment of high-quality applicants to their careers in transplantation. Applications are accepted in basic, clinical, and translational research.
Did you know there’s a transplant support system to help patients and providers with best-in-class assistance and resources? This ongoing support system assists with benefit investigation, prior authorization assistance, coordination with specialty pharmacies, prescription fulfillment navigation, and CoverMyMeds® access. There’s also a $0 co-pay card to overcome financial barriers.
In the U.S., an overall national decline in organ transplants has accompanied the substantial burden of COVID‐19. Amidst significant regional variations in COVID‐19, lung transplantation (LTx) remains a critical life‐saving operation. Our LTx practice during the early pandemic may provide a blueprint for managing LTx in an era of continued community prevalence.
Labs@HOME is a mobile phlebotomy in-home blood draw service to aid in specimen collection directly from a patient's home. Clinicians can order and customize a number of infectious disease and transplant-relatedtesting remotely
Thousands of industry professionals subscribe to AST's eNews, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure!
Clinicians have few tools to predict the risk of alloimmune injury that would guide immunosuppression management in renal transplant patients. We evaluated human leukocyte antigen (HLA) DR/DQ molecular mismatch to predict de novo donor‐specific antibodies (DSA) during the first year of transplant and explored how differences in tacrolimus exposure may modulate this risk.
Cardiac allografts from donors with a history of cocaine use (DHCU) are often discarded due to concerns regarding organ quality. We investigated long-term outcomes of de-novo adult heart transplantation (HTx) using DHCU.
Trimethoprim‐sulfamethoxazole (TMP‐SMX) is the drug of choice for Pneumocystis jirovecii pneumonia (PJP) prophylaxis and has activity against other opportunistic infections after solid organ transplant (SOT). We aimed to describe the incidence, reasons for and outcomes of use of alternative prophylactic agents (APAs) across SOT programs in our high volume centers.
Marked progress is achieved in understanding the physiopathology of COVID-19 that caused global pandemics. However, CD4+ T cell population that is critical for antibody response in COVID-19 is poorly understood.